规律间隔成簇短回文重复序列/相关蛋白9靶向Rho GDIα基因敲除质粒的构建及其对小鼠肝癌细胞系Hepa 1-6迁移的影响

曲明娟; 李延敏; 谢静; 秦苗苗; 王静; 周菊华

doi:10.16098/j.issn.0529-1356.2021.01.008

PDF(5112 KB)

解剖学报 ›› 2021, Vol. 52 ›› Issue (1) : 55-59. DOI: 10.16098/j.issn.0529-1356.2021.01.008

肿瘤生物学

规律间隔成簇短回文重复序列/相关蛋白9靶向Rho GDIα基因敲除质粒的构建及其对小鼠肝癌细胞系Hepa 1-6迁移的影响

曲明娟* 李延敏谢静秦苗苗王静周菊华

作者信息 +

Construction of Rho GDIα-sgRNAs plasmids by clustered regularly interspaced short palindromic repeats/associated protein 9 and the effect on migration of Hepa 1-6 cell line in mouse

QU Ming-juan* LI Yan-min XIE Jing QIN Miao-miao WANG Jing ZHOU Ju-hua

Author information +

文章历史 +

摘要

目的利用规律间隔成簇短回文重复序列/相关蛋白9（CRISPR/Cas9）技术构建Rho鸟苷酸解离抑制因子α（GDIα）的基因敲除载体，并探讨干扰Rho GDIα后对小鼠肝癌细胞Hepa 1-6迁移的影响。方法根据CRISPR/Cas9靶点设计原则，设计Rho GDIα的向导RNA（sgRNA）序列，并与PX458载体相连，构建Rho GDIα基因敲除重组质粒PX458-Rho GDIα-sgRNA1和PX458-Rho GDIα-sgRNA2；脂质体转染法将重组质粒转染入Hepa 1-6细胞抑制Rho GDIα的基因表达；RT-PCR法检测Rho GDIα被抑制后的mRNA表达情况；划痕法检测Rho GDIα干扰后Hepa 1-6细胞迁移距离的差异；迁移小室法检测抑制Rho GDIα后Hepa 1-6细胞迁移数量的差异。结果成功构建了Rho GDIα的CRISPR/Cas9基因敲除质粒PX458-Rho GDIα-sgRNAs；转染有PX458-Rho GDIα-sgRNA1的Hepa 1-6 细胞与对照组只转染空载体PX458的细胞相比，Rho GDIα的表达被明显抑制（P<0.05），而且该组细胞从划痕起始处迁移到空白处距离较远，从迁移小室上端迁移到底端数目明显增多，差异极其显著（P<0.01），说明Rho GDIα被抑制后肝癌细胞的迁移能力提高。结论 CRISPR/Cas9法构建的重组质粒PX458-Rho GDIα-sgRNA1可以有效抑制Rho GDIα的基因表达；Rho GDIα被抑制后明显促进小鼠肝癌细胞Hepa 1-6的迁移，提示在体情况下，Rho GDIα的表达可能起到抑制细胞迁移的重要作用，在肿瘤组织中，可以利用过表达Rho GDIα来抑制肿瘤细胞的转移。

Abstract

Objective To construct the recombinant plasmids of knocking down Rho guanine dissociation inhibitor α (GDIα) gene by using clustered regularly interspaced short palindromic repeats/associated protein 9 (CRISPR/Cas9) technique, and investigate the effect of Rho GDIα interference on the migration of Hepa 1-6 cells of mouse in order to provide the method of prevention and treatment of liver cancer. Methods To construct and identify the PX458-Rho GDIα-single guide(sg)RNAs by using CRISPR/Cas9 technique. And the Hepa 1-6 cells were transfected by liposomes with PX458-Rho GDIα-sgRNAs for 48 hours respectively, and cells treated with PX458 plasmids were used as control. The migration ability of Hepa 1-6 was checked by wound healing assay and Transwell assay, respectively. Results The expression of Rho GDIα was depressed in group of PX458-Rho GDIα-sgRNA1 transfection which was detected by using RT-PCR. The migration distance of Hepa 1-6 in PX458-Rho GDIα-sgRNA1 transfection group was significantly promoted comparing with the control group which was transfected with PX458 only, and the cell number of PX458-Rho GDIα-sgRNA1 group was more than that in control group by using transwell assay, indicating concluded that knocking down of Rho GDIα promoted the migration ability of Hepa1-6 cells.

Conclusion The result is explicit that in vivo, Rho GDIα may inhibit the migration of Hepa1-6 partially. Overexpression of Rho GDIα might be used as an important method to prevent the metastasize of carcinoma.

关键词

Key words

Clustered regularly interspaced / short palindromic repeats/associated protein 9 / Rho guanine dissociation inhibitor α / Single guide RNA / PX458 plasmid / Hepatoma Hepa1-6 cell line / RT-PCR / Mouse

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

曲明娟李延敏谢静秦苗苗王静周菊华. 规律间隔成簇短回文重复序列/相关蛋白9靶向Rho GDIα基因敲除质粒的构建及其对小鼠肝癌细胞系Hepa 1-6迁移的影响[J]. 解剖学报. 2021, 52(1): 55-59 https://doi.org/10.16098/j.issn.0529-1356.2021.01.008

QU Ming-juan LI Yan-min XIE Jing QIN Miao-miao WANG Jing ZHOU Ju-hua. Construction of Rho GDIα-sgRNAs plasmids by clustered regularly interspaced short palindromic repeats/associated protein 9 and the effect on migration of Hepa 1-6 cell line in mouse[J]. Acta Anatomica Sinica. 2021, 52(1): 55-59 https://doi.org/10.16098/j.issn.0529-1356.2021.01.008

中图分类号： R73-37

参考文献

［1］ Fiorillo M, Sanchez-Alvarez R, Sotgia F, et al. The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: implicating TIGAR in somatic resistance to endocrine therapy ［J］. Aging (Albany NY), 2018, 10(12):4000-4023.

［2］ Huang D, Lu W, Zou S, et al. Rho GDP-dissociation inhibitorα is a potential prognostic biomarker and controls telomere regulation in colorectal cancer ［J］. Cancer Sci, 2017, 108(7):1293-1302.

［3］ Cho HJ, Kim JT, Lee SJ, et al. Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion ［J］. Cancer Lett, 2018, 417(1):141-151.

［4］ Xie F, Shao S, Aziz AUR, et al. Role of Rho-specific guanine nucleotide dissociation inhibitorα regulation in cell migration ［J］. Acta Histochem, 2017, 119(3):183-189.

［5］ Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems ［J］. Science, 2013, 339(6121):819-823.

［6］ Bannikov AV, Lavrov AV. CRISPR/Cas9, the king of genome editing tools ［J］. Mol Biol (Mosk), 2017, 51(4):582-594.

［7］ Ma Y, Zhang L, Huang X. Genome modification by CRISPR/Cas9 ［J］. FEBS J, 2014, 281(23):5186-5193.

［8］ Tran NT, Sommermann T, Graf R, et al. Efficient CRISPR/Cas9-mediated gene knockin in mouse hematopoietic stem and progenitor cells ［J］. Cell Rep, 2019, 28(13):3510-3522.

［9］ Lei YT, Liu L, Zuo YZh, et al. Effect of dihydromyricetin on the proliferation and migration ability in choriocarcinoma JEG-3 and JAR cells ［J］. Acta Anatomica Sinica, 2019, 50(3): 317-323. (in Chinese)

雷赟涛，刘镭，左彦珍，等. 二氢杨梅素对绒毛膜癌细胞增殖和迁移能力的影响［J］. 解剖学报，2019, 50(3): 317-323.

［10］ Wang XJ，Yang YJ，Tian HN，et al. Effects of annexin A5 low expression on migration and invasion of HeLa cells ［J］. Acta Anatomica Sinica, 2019, 47(4):487-492. (in Chinese)

王小杰，杨艳杰，田焕娜，等. 膜联蛋白A5低表达对人宫颈癌HeLa细胞迁移和侵袭的影响［J］. 解剖学报，2016, 47(4):487-492.

［11］ Tanaka S, Ishihara N, Suzuki S, et al. Fatty acid desaturase 2 is up-regulated by the treatment with statin through geranylgeranyl pyrophosphate-dependent Rho kinase pathway in HepG2 cells ［J］. Sci Rep, 2019, 9(1):10009-10017.

［12］ Senoo H, Kamimura Y, Kimura R, et al. Phosphorylated Rho-GDP directly activates mTORC2 kinase towards AKT through dimerization with Ras-GTP to regulate cell migration ［J］. Nat Cell Biol, 2019, 21(7):867-878.

［13］ Bozza WP, Zhang Y, Hallett K, et al. Rho GDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression ［J］. Oncotarget, 2015, 6(32):32723-32736.

［14］ Wang C, Wang X, Su Z, et al. MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1 ［J］. Oncotarget, 2015, 6(34):36231-36244.

［15］ Pathak B, Zhao S, Manoharan M, et al. Dualtargeting by CRISPR/Cas9 leads to efficient point mutagenesis but only rare targeted deletions in the rice genome ［J］. 3 Biotech, 2019, 9(4):158-169.

［16］ Mehta D, Stürchler A, Anjanappa RB, et al. Linking CRISPR-Cas9 interference in cassava to the evolution of editing-resistant geminiviruses ［J］. Genome Biol, 2019, 20(1):80-89.

［17］ He X, Wang Y, Yang F, et al. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNAGln-processing system in human cells ［J］. J Biol Chem, 2019, 294(23):9308-9315.

［18］ Qi YX, Qu MJ, Long DK, et al. Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: a proteomic analysis ［J］. Cardiovasc Res, 2008, 80(1):114-122.